Metabolic Risk Assessment in Prepubertal Children With Congenital Hypothyroidism
NCT ID: NCT07126353
Last Updated: 2025-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
170 participants
OBSERVATIONAL
2025-09-30
2026-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality of Life and Long-term Outcome of Adequately Treated Congenital Hypothyroidism
NCT06864039
ASQ Scores of Transient Hypothyroxinemia of Prematurity
NCT05901623
Influence of Initial Levothyroxine Dose on Neurodevelopmental and Growth Outcomes in Congenital Hypothyroidism
NCT05371262
Comparison of Levothyroxine Formulations in the Treatment of Congenital Hypothyroidism
NCT06724224
Preconceptional Thyroid Screening and Childhood Nerocognitive Function
NCT01744743
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Thyroid hormones play a crucial role not only in growth and organ development but also in metabolic homeostasis. Thyroid function lies at the crossroads of multiple metabolic pathways. They have multiple effects on glucose and lipid metabolism, specifically by increasing glucose levels, fatty acid oxidation in muscle and liver, and lipolysis in adipose tissue. They also contribute to blood pressure regulation, thereby influencing the prevalence of metabolic syndrome, which is itself a key predictor of type 2 diabetes, cardiovascular diseases, and neurodegenerative conditions.Thyroid function plays a central regulatory role at the intersection of key metabolic pathways. Although, the role of thyroid hormones in metabolic processes is well established, and a bidirectional relationship between metabolic dysfunction and thyroid hypofunction has been reported in the adult population, data on metabolic risk in pediatric patients with congenital hypothyroidism are currently lacking.
The primary aim of this multicenter project is to assess the prevalence of metabolic syndrome in patients with congenital hypothyroidism and to determine whether this population presents a higher metabolic risk profile compared to the general population. As secondary objectives, this prospective study aims to:
1. Define the prevalence and severity score of metabolic syndrome in a prepubertal pediatric cohort with congenital hypothyroidism, compared to a pediatric population with obesity.
2. Evaluate the correlations between individual metabolic dysfunction parameters and the clinical and hormonal profile (including thyroid hormone levels and thyroid hormone sensitivity indices).
3. Assess the correlations between the metabolic profile and renal function.
4. Assess the correlations between the hormonal profile and renal function. To achieve these objectives, auxological parameters, vital signs (including blood pressure and heart rate), and metabolic profile data (glucose and lipid profiles, renal function, and hormonal status - FT3, FT4, TSH and thyroid hormone resistence indices TSHI, TT4RI, TT3RI, TFQI, PTFQI) will be collected for each enrolled subject. These parameters will be evaluated on peripheral blood samples collected during routine blood monitoring already scheduled according to established follow up. The potential presence of metabolic syndrome will be evaluated in each enrolled patient. The severity of the metabolic disorder will be evaluated using the Metabolic Score (MetS).
Data analysis will be performed using the statistical packages R 4.0.5 (R Core Team, 2021) and STATA (version 15.1, 2017, Stata Corporation, College Station, Texas, USA).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Permanent congenital hypothyroidism
170 patients in prepubertal age.
prospective observational study (clinical, hormonal and auxological data)
We collect clinical, hormonal and auxological data and compare them between the two groups.
Healthy childrens normal weight
170 childrens in prepubertal age.
prospective observational study (clinical, hormonal and auxological data)
We collect clinical, hormonal and auxological data and compare them between the two groups.
Healthy childrens overweight/obese
170 patients in prepubertal age
prospective observational study (clinical, hormonal and auxological data)
We collect clinical, hormonal and auxological data and compare them between the two groups.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
prospective observational study (clinical, hormonal and auxological data)
We collect clinical, hormonal and auxological data and compare them between the two groups.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Permanent congenital hypothyroidism
* All ethnic groups
* Informed consent signature
Exclusion Criteria
* Pubertal stage Tanner 2-5
* Transient congenital hypothyroidism or other type of hypothyroidism
5 Years
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federico II University
OTHER
IRCCS Ospedale San Raffaele
OTHER
Policlinico di Bari Giovanni XXIII
UNKNOWN
Azienda Ospedaliero Universitaria Policlinico Modena
OTHER
Azienda Ospedaliero-Universitaria di Parma
OTHER
Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna
OTHER
Azienda Ospedaliera Sant'Anna
OTHER
University Hospital Perugia
UNKNOWN
University of L'Aquila
OTHER
Clinica Pediatrica Università di Novara
UNKNOWN
Santobono-Pausilpon Hospital
UNKNOWN
Policlinico G . Martino, Messina Italy
UNKNOWN
IRCCS Azienda Ospedaliero-Universitaria di Bologna
OTHER
University Hospital of Ancona
UNKNOWN
Buzzi Children's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Valeria Calcaterra
Prof
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Buzzi Children's Hospital
Milan, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Jostel A, Ryder WD, Shalet SM. The use of thyroid function tests in the diagnosis of hypopituitarism: definition and evaluation of the TSH Index. Clin Endocrinol (Oxf). 2009 Oct;71(4):529-34. doi: 10.1111/j.1365-2265.2009.03534.x. Epub 2009 Feb 18.
Iwamoto Y, Kimura T, Tatsumi F, Sugisaki T, Kubo M, Nakao E, Dan K, Wamata R, Iwamoto H, Takahashi K, Sanada J, Fushimi Y, Katakura Y, Shimoda M, Nakanishi S, Mune T, Kaku K, Kaneto H. Effect of Hyperglycemia-Related Acute Metabolic Disturbance on Thyroid Function Parameters in Adults. Front Endocrinol (Lausanne). 2022 May 12;13:869869. doi: 10.3389/fendo.2022.869869. eCollection 2022.
Dietrich JW, Landgrafe-Mende G, Wiora E, Chatzitomaris A, Klein HH, Midgley JE, Hoermann R. Calculated Parameters of Thyroid Homeostasis: Emerging Tools for Differential Diagnosis and Clinical Research. Front Endocrinol (Lausanne). 2016 Jun 9;7:57. doi: 10.3389/fendo.2016.00057. eCollection 2016.
Laclaustra M, Moreno-Franco B, Lou-Bonafonte JM, Mateo-Gallego R, Casasnovas JA, Guallar-Castillon P, Cenarro A, Civeira F. Impaired Sensitivity to Thyroid Hormones Is Associated With Diabetes and Metabolic Syndrome. Diabetes Care. 2019 Feb;42(2):303-310. doi: 10.2337/dc18-1410. Epub 2018 Dec 14.
Lakhani G, Patel P, Patel TC. A Cross-Sectional Study on the Prevalence of Subclinical Hypothyroidism in Metabolic Syndrome Patients at a Tertiary Care Hospital. Cureus. 2024 Aug 26;16(8):e67851. doi: 10.7759/cureus.67851. eCollection 2024 Aug.
Thakur R, Kumar S, Neeraj RK, Saleem M, Kumar C, Mohan L. Evaluation of the Association between Insulin Resistance and Subclinical Hypothyroidism Using Triglyceride-Glucose Index: a Cross-Sectional Study. Maedica (Bucur). 2024 Jun;19(2):255-259. doi: 10.26574/maedica.2024.19.2.255.
Verma DP, Chaudhary SC, Singh A, Sawlani KK, Gupta KK, Usman K, Reddy HD, Patel ML, Verma SK, Atam V. Hypothyroidism in Metabolic Syndrome. Ann Afr Med. 2024 Oct 1;23(4):717-722. doi: 10.4103/aam.aam_25_24. Epub 2024 Sep 14.
Xie H, Li N, Zhou G, He Z, Xu X, Liu Q, Wang H, Han J, Shen L, Yu P, Chen J, Chen X. The association between the thyroid feedback quantile-based index and serum uric acid in U.S. adults. Eur J Med Res. 2023 Jul 27;28(1):259. doi: 10.1186/s40001-023-01214-3.
Xie Y, Wang Z, Chen Z. Analysis of Subclinical Thyroid Dysfunction and Metabolic Abnormality in 28568 Healthy People. Int J Endocrinol. 2023 Oct 16;2023:5216945. doi: 10.1155/2023/5216945. eCollection 2023.
Zhong L, Liu S, Yang Y, Xie T, Liu J, Zhao H, Tan G. Metabolic syndrome and risk of subclinical hypothyroidism: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2024 Jun 25;15:1399236. doi: 10.3389/fendo.2024.1399236. eCollection 2024.
Di Bonito P, Corica D, Marzuillo P, Di Sessa A, Licenziati MR, Faienza MF, Calcaterra V, Franco F, Maltoni G, Valerio G, Wasniewska M. Sensitivity to Thyroid Hormones and Reduced Glomerular Filtration in Children and Adolescents with Overweight or Obesity. Horm Res Paediatr. 2024;97(4):383-387. doi: 10.1159/000534472. Epub 2023 Oct 9.
Calcaterra V, Mameli C, Macedoni M, De Silvestri A, Sgambetterra L, Nosenzo F, Redaelli FC, Petitti A, Bosetti A, Zuccotti G. Investigating the connection among thyroid function, sensitivity to thyroid hormones, and metabolic syndrome in euthyroid children and adolescents affected by type 1 diabetes. J Pediatr Endocrinol Metab. 2024 Mar 12;37(4):347-352. doi: 10.1515/jpem-2023-0565. Print 2024 Apr 25.
Calcaterra V, Gazzarri A, De Silvestri A, Madia C, Baldassarre P, Rossi V, Garella V, Zuccotti G. Thyroid function, sensitivity to thyroid hormones, and metabolic syndrome in euthyroid children and adolescents with Down syndrome. J Endocrinol Invest. 2023 Nov;46(11):2319-2325. doi: 10.1007/s40618-023-02086-4. Epub 2023 Apr 11.
Biondi B. Subclinical Hypothyroidism in Patients with Obesity and Metabolic Syndrome: A Narrative Review. Nutrients. 2023 Dec 27;16(1):87. doi: 10.3390/nu16010087.
Alwan H, Ribero VA, Efthimiou O, Del Giovane C, Rodondi N, Duntas L. A systematic review and meta-analysis investigating the relationship between metabolic syndrome and the incidence of thyroid diseases. Endocrine. 2024 May;84(2):320-327. doi: 10.1007/s12020-023-03503-7. Epub 2023 Sep 9.
Alsulami SS, Baig M, Albeladi AH, Alyoubi SB, Alsubaie SA, Albeladi SA, Ghamri KA, Alraiqi AMS, Alyoubi SM, Almutairi WA. Correlation between Subclinical Hypothyroidism and Metabolic Syndrome: A Retrospective Study. Saudi J Med Med Sci. 2023 Jul-Sep;11(3):250-256. doi: 10.4103/sjmms.sjmms_225_22. Epub 2023 Jul 15.
Abha P, Keshari JR, Sinha SR, Nishant K, Kumari R, Prakash P. Association of Thyroid Function With Lipid Profile in Patients With Metabolic Syndrome: A Prospective Cross-Sectional Study in the Indian Population. Cureus. 2023 Sep 5;15(9):e44745. doi: 10.7759/cureus.44745. eCollection 2023 Sep.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CET 503-2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.